Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Osteosarcoma | 21 | 2023 | 255 | 4.670 |
Why?
|
Bone Neoplasms | 17 | 2023 | 426 | 3.460 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p27 | 2 | 2020 | 60 | 1.160 |
Why?
|
Biomarkers, Tumor | 9 | 2017 | 1534 | 1.160 |
Why?
|
Blood Proteins | 3 | 2012 | 124 | 0.950 |
Why?
|
Gene Expression Profiling | 11 | 2023 | 1757 | 0.870 |
Why?
|
Telomere Shortening | 1 | 2021 | 33 | 0.740 |
Why?
|
Histiocytosis, Langerhans-Cell | 5 | 2020 | 224 | 0.680 |
Why?
|
Neoplasms, Second Primary | 1 | 2021 | 146 | 0.660 |
Why?
|
Proteomics | 3 | 2012 | 506 | 0.650 |
Why?
|
p21-Activated Kinases | 1 | 2020 | 57 | 0.650 |
Why?
|
Brain Neoplasms | 8 | 2021 | 1316 | 0.640 |
Why?
|
Proteome | 4 | 2021 | 246 | 0.640 |
Why?
|
Platelet Factor 4 | 2 | 2017 | 22 | 0.640 |
Why?
|
Cell Movement | 3 | 2020 | 850 | 0.640 |
Why?
|
Thyroid Neoplasms | 1 | 2021 | 189 | 0.630 |
Why?
|
Lung Neoplasms | 3 | 2020 | 1653 | 0.630 |
Why?
|
Cancer Survivors | 1 | 2021 | 213 | 0.600 |
Why?
|
Serum Amyloid A Protein | 1 | 2017 | 29 | 0.550 |
Why?
|
Systems Biology | 2 | 2018 | 58 | 0.530 |
Why?
|
Proto-Oncogene Proteins B-raf | 3 | 2019 | 193 | 0.530 |
Why?
|
Chemokine CXCL10 | 1 | 2016 | 53 | 0.520 |
Why?
|
Neoplasm Metastasis | 4 | 2015 | 704 | 0.500 |
Why?
|
Oligonucleotide Array Sequence Analysis | 10 | 2015 | 1033 | 0.470 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 3 | 2011 | 61 | 0.460 |
Why?
|
Prognosis | 11 | 2022 | 4683 | 0.440 |
Why?
|
Child | 28 | 2023 | 24609 | 0.430 |
Why?
|
Cell Line, Tumor | 12 | 2023 | 3422 | 0.420 |
Why?
|
Medulloblastoma | 5 | 2018 | 548 | 0.380 |
Why?
|
Adolescent | 19 | 2022 | 19412 | 0.380 |
Why?
|
Blood Chemical Analysis | 1 | 2012 | 81 | 0.370 |
Why?
|
Viral Proteins | 2 | 2004 | 346 | 0.360 |
Why?
|
Biomarkers, Pharmacological | 1 | 2010 | 10 | 0.360 |
Why?
|
Chemokines, CXC | 1 | 2010 | 37 | 0.340 |
Why?
|
Neoplasm Proteins | 3 | 2015 | 680 | 0.340 |
Why?
|
Neuroblastoma | 2 | 2013 | 529 | 0.330 |
Why?
|
Membrane Proteins | 2 | 2017 | 1538 | 0.330 |
Why?
|
Mice, SCID | 7 | 2020 | 587 | 0.320 |
Why?
|
MAP Kinase Signaling System | 3 | 2021 | 313 | 0.320 |
Why?
|
Cell Culture Techniques | 1 | 2020 | 275 | 0.310 |
Why?
|
Transcriptome | 3 | 2023 | 978 | 0.310 |
Why?
|
Humans | 50 | 2023 | 125025 | 0.310 |
Why?
|
Cell Proliferation | 7 | 2022 | 2377 | 0.300 |
Why?
|
Mice | 18 | 2023 | 17711 | 0.300 |
Why?
|
Repressor Proteins | 2 | 2004 | 827 | 0.290 |
Why?
|
Nucleic Acid Hybridization | 2 | 2008 | 394 | 0.290 |
Why?
|
Gene Amplification | 4 | 2015 | 235 | 0.280 |
Why?
|
Operator Regions, Genetic | 2 | 2004 | 5 | 0.280 |
Why?
|
Xenograft Model Antitumor Assays | 6 | 2018 | 914 | 0.280 |
Why?
|
Biomarkers | 5 | 2022 | 3105 | 0.270 |
Why?
|
RNA, Long Noncoding | 2 | 2022 | 218 | 0.270 |
Why?
|
Antineoplastic Agents | 3 | 2021 | 1714 | 0.260 |
Why?
|
Chromosome Aberrations | 3 | 2008 | 615 | 0.260 |
Why?
|
Algorithms | 3 | 2013 | 1630 | 0.250 |
Why?
|
Glioblastoma | 2 | 2021 | 347 | 0.250 |
Why?
|
Survival Rate | 5 | 2016 | 2051 | 0.250 |
Why?
|
Ependymoma | 2 | 2022 | 164 | 0.250 |
Why?
|
Neoplastic Stem Cells | 3 | 2014 | 325 | 0.240 |
Why?
|
Young Adult | 7 | 2021 | 9054 | 0.240 |
Why?
|
Tumor Cells, Cultured | 4 | 2020 | 1070 | 0.240 |
Why?
|
Adult | 11 | 2021 | 29452 | 0.230 |
Why?
|
Animals | 20 | 2023 | 34205 | 0.230 |
Why?
|
Escherichia coli | 4 | 1998 | 967 | 0.230 |
Why?
|
Sarcoma | 1 | 2007 | 184 | 0.230 |
Why?
|
DNA-Binding Proteins | 3 | 2004 | 2055 | 0.230 |
Why?
|
Protein Array Analysis | 3 | 2012 | 101 | 0.230 |
Why?
|
Langerhans Cells | 2 | 2017 | 21 | 0.230 |
Why?
|
Tumor Suppressor Protein p53 | 3 | 2015 | 743 | 0.230 |
Why?
|
Male | 19 | 2021 | 61429 | 0.220 |
Why?
|
Drug Resistance, Neoplasm | 4 | 2021 | 734 | 0.220 |
Why?
|
Computational Biology | 2 | 2017 | 819 | 0.220 |
Why?
|
Female | 21 | 2021 | 66669 | 0.210 |
Why?
|
Glycoproteins | 3 | 2020 | 362 | 0.210 |
Why?
|
Mice, Inbred NOD | 4 | 2018 | 299 | 0.210 |
Why?
|
Longitudinal Studies | 2 | 2021 | 1320 | 0.210 |
Why?
|
Osteopontin | 2 | 2018 | 49 | 0.210 |
Why?
|
Child, Preschool | 12 | 2021 | 14150 | 0.210 |
Why?
|
Survival Analysis | 4 | 2020 | 1496 | 0.210 |
Why?
|
Case-Control Studies | 3 | 2021 | 3310 | 0.210 |
Why?
|
Pyridoxal Phosphate | 3 | 1998 | 14 | 0.200 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2010 | 1245 | 0.200 |
Why?
|
Leukemia, Myeloid, Acute | 2 | 2021 | 522 | 0.200 |
Why?
|
Tripartite Motif-Containing Protein 28 | 1 | 2022 | 16 | 0.200 |
Why?
|
DNA | 3 | 2022 | 1606 | 0.190 |
Why?
|
Symporters | 1 | 2022 | 71 | 0.190 |
Why?
|
Models, Genetic | 2 | 2004 | 760 | 0.190 |
Why?
|
Neoplasm Staging | 3 | 2016 | 1275 | 0.190 |
Why?
|
Bacteriophage P22 | 1 | 2001 | 1 | 0.190 |
Why?
|
Chromosome Mapping | 1 | 2004 | 1086 | 0.180 |
Why?
|
Leukocytes, Mononuclear | 2 | 2020 | 325 | 0.180 |
Why?
|
Apoptosis | 6 | 2018 | 1819 | 0.180 |
Why?
|
T-Lymphocytes | 2 | 2021 | 1716 | 0.180 |
Why?
|
Bacterial Proteins | 2 | 1997 | 887 | 0.180 |
Why?
|
Radiotherapy | 1 | 2021 | 138 | 0.180 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2021 | 91 | 0.170 |
Why?
|
STAT5 Transcription Factor | 1 | 2021 | 88 | 0.170 |
Why?
|
Gene Expression Regulation, Neoplastic | 7 | 2022 | 1984 | 0.170 |
Why?
|
Escherichia coli Proteins | 3 | 1998 | 303 | 0.170 |
Why?
|
Databases, Factual | 2 | 2017 | 1172 | 0.160 |
Why?
|
Protein Interaction Maps | 1 | 2020 | 79 | 0.160 |
Why?
|
Lymphohistiocytosis, Hemophagocytic | 1 | 2021 | 146 | 0.160 |
Why?
|
Loss of Heterozygosity | 2 | 2013 | 130 | 0.160 |
Why?
|
Cerebellar Neoplasms | 2 | 2014 | 443 | 0.160 |
Why?
|
Immunoenzyme Techniques | 3 | 2016 | 256 | 0.160 |
Why?
|
Antibodies, Monoclonal, Humanized | 1 | 2023 | 509 | 0.160 |
Why?
|
STAT3 Transcription Factor | 1 | 2021 | 218 | 0.160 |
Why?
|
Cytoplasm | 1 | 2020 | 289 | 0.150 |
Why?
|
Antigens, CD | 3 | 2020 | 429 | 0.150 |
Why?
|
Drug Repositioning | 1 | 2018 | 23 | 0.150 |
Why?
|
Dendritic Cells | 2 | 2020 | 413 | 0.150 |
Why?
|
Enzyme Activation | 1 | 2020 | 623 | 0.150 |
Why?
|
Digoxin | 1 | 2018 | 43 | 0.150 |
Why?
|
Cytokines | 2 | 2016 | 1292 | 0.150 |
Why?
|
Tumor Suppressor Proteins | 1 | 2021 | 471 | 0.150 |
Why?
|
Receptor, EphA2 | 1 | 2018 | 29 | 0.150 |
Why?
|
Interleukin-13 Receptor alpha2 Subunit | 1 | 2018 | 20 | 0.150 |
Why?
|
Antigenic Variation | 1 | 2018 | 39 | 0.150 |
Why?
|
Hematopoietic Stem Cell Transplantation | 2 | 2023 | 1097 | 0.140 |
Why?
|
Recurrence | 3 | 2022 | 1388 | 0.140 |
Why?
|
Apoptosis Regulatory Proteins | 2 | 2015 | 151 | 0.140 |
Why?
|
Receptors, Cyclic AMP | 1 | 1997 | 3 | 0.140 |
Why?
|
Transferases | 1 | 1997 | 4 | 0.140 |
Why?
|
Tissue Banks | 1 | 2017 | 27 | 0.140 |
Why?
|
Alkyl and Aryl Transferases | 1 | 1997 | 18 | 0.140 |
Why?
|
Transaminases | 1 | 1997 | 32 | 0.140 |
Why?
|
Gene Expression Regulation, Bacterial | 2 | 1998 | 157 | 0.140 |
Why?
|
Sepsis | 1 | 2021 | 483 | 0.130 |
Why?
|
Proto-Oncogene Proteins c-myc | 2 | 2015 | 210 | 0.130 |
Why?
|
Cyclic AMP | 1 | 1997 | 244 | 0.130 |
Why?
|
Combined Modality Therapy | 3 | 2010 | 1237 | 0.130 |
Why?
|
Neurodegenerative Diseases | 2 | 2018 | 249 | 0.130 |
Why?
|
Suppression, Genetic | 1 | 1996 | 43 | 0.130 |
Why?
|
Ligases | 1 | 1996 | 47 | 0.130 |
Why?
|
Transplantation, Heterologous | 2 | 2014 | 261 | 0.130 |
Why?
|
Sarcoma, Experimental | 1 | 2015 | 16 | 0.120 |
Why?
|
Cysteine-Rich Protein 61 | 1 | 2015 | 5 | 0.120 |
Why?
|
Software | 2 | 2012 | 687 | 0.120 |
Why?
|
Mitoxantrone | 1 | 2015 | 26 | 0.120 |
Why?
|
Chromosomes, Human, Pair 8 | 2 | 2006 | 79 | 0.120 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 5 | 2014 | 1294 | 0.120 |
Why?
|
MicroRNAs | 1 | 2021 | 858 | 0.120 |
Why?
|
Polycomb Repressive Complex 1 | 1 | 2014 | 35 | 0.120 |
Why?
|
Point Mutation | 1 | 1996 | 350 | 0.110 |
Why?
|
Antigens, CD1d | 1 | 2014 | 21 | 0.110 |
Why?
|
Receptor, ErbB-2 | 1 | 2018 | 514 | 0.110 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2018 | 480 | 0.110 |
Why?
|
Computer Simulation | 1 | 2017 | 650 | 0.110 |
Why?
|
Risk | 1 | 2016 | 759 | 0.110 |
Why?
|
Disease-Free Survival | 1 | 2016 | 880 | 0.110 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2015 | 214 | 0.110 |
Why?
|
DNA Copy Number Variations | 2 | 2022 | 963 | 0.110 |
Why?
|
Supratentorial Neoplasms | 1 | 2014 | 37 | 0.110 |
Why?
|
Neuroectodermal Tumors, Primitive | 1 | 2014 | 57 | 0.110 |
Why?
|
Infant | 9 | 2021 | 12610 | 0.110 |
Why?
|
Wnt Signaling Pathway | 1 | 2015 | 193 | 0.110 |
Why?
|
Natural Killer T-Cells | 1 | 2014 | 84 | 0.100 |
Why?
|
Viral Regulatory and Accessory Proteins | 2 | 2004 | 37 | 0.100 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 1 | 2013 | 94 | 0.100 |
Why?
|
Genome, Human | 2 | 2013 | 1293 | 0.100 |
Why?
|
Diagnosis, Differential | 3 | 2021 | 1893 | 0.100 |
Why?
|
Wheat Germ Agglutinins | 1 | 2012 | 14 | 0.100 |
Why?
|
Transcription, Genetic | 2 | 1997 | 1708 | 0.100 |
Why?
|
Down-Regulation | 1 | 2014 | 692 | 0.100 |
Why?
|
Glycogen | 1 | 2012 | 63 | 0.100 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2015 | 560 | 0.100 |
Why?
|
Ion Exchange | 1 | 2012 | 5 | 0.100 |
Why?
|
Follow-Up Studies | 3 | 2016 | 5167 | 0.100 |
Why?
|
Surveys and Questionnaires | 1 | 2021 | 3674 | 0.090 |
Why?
|
Calibration | 1 | 2012 | 87 | 0.090 |
Why?
|
Disease Models, Animal | 4 | 2021 | 4405 | 0.090 |
Why?
|
Hedgehog Proteins | 1 | 2013 | 257 | 0.090 |
Why?
|
Biomedical Research | 1 | 2017 | 516 | 0.090 |
Why?
|
Molecular Weight | 1 | 2012 | 382 | 0.090 |
Why?
|
Serum Albumin | 1 | 2012 | 113 | 0.090 |
Why?
|
Signal Transduction | 4 | 2022 | 4595 | 0.090 |
Why?
|
Peptides | 1 | 2014 | 812 | 0.090 |
Why?
|
Cytoskeleton | 1 | 2012 | 169 | 0.090 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2008 | 774 | 0.090 |
Why?
|
Wnt Proteins | 1 | 2012 | 216 | 0.090 |
Why?
|
Patient-Specific Modeling | 1 | 2020 | 8 | 0.090 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2013 | 2654 | 0.090 |
Why?
|
Chemokine CXCL6 | 1 | 2010 | 16 | 0.090 |
Why?
|
Serial Passage | 1 | 2020 | 19 | 0.090 |
Why?
|
Up-Regulation | 3 | 2021 | 874 | 0.090 |
Why?
|
Neoplasms, Experimental | 1 | 2011 | 216 | 0.090 |
Why?
|
Chemokine CXCL12 | 1 | 2010 | 37 | 0.090 |
Why?
|
Macrophages | 1 | 2014 | 626 | 0.090 |
Why?
|
Tissue Array Analysis | 1 | 2010 | 137 | 0.080 |
Why?
|
RNA, Messenger | 3 | 2014 | 2813 | 0.080 |
Why?
|
Binding Sites | 2 | 2004 | 1303 | 0.080 |
Why?
|
Epidermis | 1 | 2010 | 62 | 0.080 |
Why?
|
Glioma | 1 | 2014 | 513 | 0.080 |
Why?
|
Mutation | 6 | 2019 | 5897 | 0.080 |
Why?
|
Neoplasm Transplantation | 1 | 2020 | 384 | 0.080 |
Why?
|
Sequence Analysis, RNA | 2 | 2023 | 372 | 0.080 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2010 | 366 | 0.080 |
Why?
|
Carrier Proteins | 1 | 2015 | 1027 | 0.080 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2012 | 681 | 0.080 |
Why?
|
Matrix Metalloproteinase 13 | 1 | 2009 | 11 | 0.080 |
Why?
|
Inhibitor of Apoptosis Proteins | 1 | 2009 | 47 | 0.080 |
Why?
|
Blood Cells | 1 | 2019 | 50 | 0.080 |
Why?
|
Feasibility Studies | 1 | 2012 | 760 | 0.080 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2011 | 407 | 0.080 |
Why?
|
Immunoglobulin G | 1 | 2012 | 780 | 0.080 |
Why?
|
Biopsy | 2 | 2018 | 1242 | 0.070 |
Why?
|
Sensitivity and Specificity | 2 | 2011 | 2054 | 0.070 |
Why?
|
Texas | 1 | 2016 | 3571 | 0.070 |
Why?
|
Nucleic Acid Amplification Techniques | 2 | 2004 | 65 | 0.070 |
Why?
|
RNA, Small Interfering | 2 | 2023 | 670 | 0.070 |
Why?
|
Chromosome Deletion | 2 | 2015 | 653 | 0.070 |
Why?
|
Matrix Metalloproteinases | 1 | 2007 | 65 | 0.070 |
Why?
|
Genes, Bacterial | 2 | 1998 | 210 | 0.070 |
Why?
|
Chromosomes, Human, Pair 6 | 2 | 2004 | 143 | 0.070 |
Why?
|
Peptide Elongation Factor 1 | 1 | 2006 | 9 | 0.070 |
Why?
|
Cohort Studies | 1 | 2016 | 4819 | 0.070 |
Why?
|
Osteochondroma | 1 | 2006 | 5 | 0.070 |
Why?
|
DNA Methylation | 2 | 2023 | 1053 | 0.060 |
Why?
|
Databases, Genetic | 1 | 2019 | 475 | 0.060 |
Why?
|
Ribosomal Proteins | 1 | 2006 | 71 | 0.060 |
Why?
|
Mannose-Binding Lectins | 2 | 2020 | 24 | 0.060 |
Why?
|
Razoxane | 1 | 2005 | 9 | 0.060 |
Why?
|
Fluorescent Dyes | 2 | 2011 | 261 | 0.060 |
Why?
|
Middle Aged | 2 | 2021 | 26670 | 0.060 |
Why?
|
Lectins, C-Type | 2 | 2020 | 71 | 0.060 |
Why?
|
Twist-Related Protein 1 | 1 | 2005 | 36 | 0.060 |
Why?
|
Disease Progression | 1 | 2011 | 2083 | 0.060 |
Why?
|
Nuclear Proteins | 2 | 2014 | 1273 | 0.060 |
Why?
|
Rhabdomyosarcoma | 1 | 2007 | 191 | 0.060 |
Why?
|
Doxorubicin | 1 | 2005 | 288 | 0.060 |
Why?
|
Chromosomes, Human, Pair 12 | 1 | 2004 | 92 | 0.060 |
Why?
|
Clone Cells | 1 | 2004 | 167 | 0.060 |
Why?
|
Cisplatin | 1 | 2005 | 249 | 0.060 |
Why?
|
Chemokine CXCL9 | 1 | 2023 | 14 | 0.050 |
Why?
|
Reproducibility of Results | 1 | 2010 | 2876 | 0.050 |
Why?
|
Predictive Value of Tests | 2 | 2008 | 2181 | 0.050 |
Why?
|
Hydatidiform Mole | 2 | 1994 | 18 | 0.050 |
Why?
|
Melphalan | 1 | 2023 | 41 | 0.050 |
Why?
|
fas Receptor | 1 | 2023 | 41 | 0.050 |
Why?
|
Azacitidine | 1 | 2023 | 54 | 0.050 |
Why?
|
Methotrexate | 1 | 2005 | 336 | 0.050 |
Why?
|
Alemtuzumab | 1 | 2023 | 86 | 0.050 |
Why?
|
Amino Acid Substitution | 1 | 2004 | 398 | 0.050 |
Why?
|
Receptors, Growth Factor | 1 | 2022 | 35 | 0.050 |
Why?
|
Microarray Analysis | 2 | 2017 | 236 | 0.050 |
Why?
|
Chromosomes, Human, Pair 17 | 1 | 2004 | 372 | 0.050 |
Why?
|
Uterine Neoplasms | 2 | 1994 | 104 | 0.050 |
Why?
|
CpG Islands | 1 | 2023 | 330 | 0.050 |
Why?
|
Receptor, IGF Type 1 | 1 | 2022 | 92 | 0.050 |
Why?
|
Karyotyping | 2 | 2015 | 319 | 0.050 |
Why?
|
Dissection | 1 | 2021 | 54 | 0.050 |
Why?
|
Magnetic Resonance Imaging | 1 | 2013 | 3597 | 0.050 |
Why?
|
Models, Biological | 2 | 2017 | 1461 | 0.050 |
Why?
|
Salmonella | 1 | 2001 | 28 | 0.050 |
Why?
|
Mice, Inbred C57BL | 3 | 2017 | 4415 | 0.050 |
Why?
|
Culture Media, Conditioned | 1 | 2021 | 82 | 0.050 |
Why?
|
Fluorescence | 1 | 2001 | 96 | 0.050 |
Why?
|
Genomic Instability | 2 | 2015 | 230 | 0.040 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2021 | 69 | 0.040 |
Why?
|
Thermodynamics | 1 | 2001 | 145 | 0.040 |
Why?
|
Cryopreservation | 1 | 2021 | 73 | 0.040 |
Why?
|
Interleukin-13 | 1 | 2021 | 97 | 0.040 |
Why?
|
Substrate Specificity | 1 | 2001 | 295 | 0.040 |
Why?
|
In Situ Hybridization, Fluorescence | 2 | 2015 | 769 | 0.040 |
Why?
|
Single-Cell Analysis | 1 | 2023 | 291 | 0.040 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 2021 | 173 | 0.040 |
Why?
|
Antigens, CD1 | 1 | 2020 | 21 | 0.040 |
Why?
|
Tissue Donors | 1 | 2023 | 483 | 0.040 |
Why?
|
Ceruloplasmin | 1 | 1999 | 15 | 0.040 |
Why?
|
Comparative Genomic Hybridization | 2 | 2013 | 573 | 0.040 |
Why?
|
Ubiquitin-Protein Ligases | 2 | 2014 | 359 | 0.040 |
Why?
|
Myeloid Cells | 1 | 2020 | 102 | 0.040 |
Why?
|
Mutagenesis, Insertional | 2 | 1999 | 150 | 0.040 |
Why?
|
Placenta | 2 | 1994 | 507 | 0.040 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2005 | 1155 | 0.040 |
Why?
|
Transcriptional Activation | 1 | 2021 | 486 | 0.040 |
Why?
|
Interferon-gamma | 1 | 2021 | 505 | 0.040 |
Why?
|
Aldehyde Oxidoreductases | 2 | 2014 | 19 | 0.040 |
Why?
|
Gene Dosage | 2 | 2013 | 444 | 0.040 |
Why?
|
Radiation, Ionizing | 1 | 2018 | 42 | 0.040 |
Why?
|
Base Sequence | 2 | 2001 | 3107 | 0.040 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2015 | 561 | 0.040 |
Why?
|
Pyridoxal Kinase | 1 | 1998 | 2 | 0.040 |
Why?
|
Oxidoreductases | 1 | 1998 | 92 | 0.040 |
Why?
|
RNA, Neoplasm | 2 | 2009 | 140 | 0.040 |
Why?
|
Models, Molecular | 1 | 2001 | 1084 | 0.040 |
Why?
|
Insulin-Like Growth Factor Binding Protein 2 | 1 | 2017 | 9 | 0.040 |
Why?
|
Epigenesis, Genetic | 1 | 2022 | 703 | 0.040 |
Why?
|
Leucine-Responsive Regulatory Protein | 1 | 1997 | 1 | 0.040 |
Why?
|
3-Phosphoshikimate 1-Carboxyvinyltransferase | 1 | 1997 | 2 | 0.040 |
Why?
|
Minor Histocompatibility Antigens | 1 | 2017 | 35 | 0.030 |
Why?
|
Multivariate Analysis | 1 | 2021 | 1425 | 0.030 |
Why?
|
Operon | 1 | 1997 | 50 | 0.030 |
Why?
|
Proportional Hazards Models | 1 | 2021 | 1361 | 0.030 |
Why?
|
Tumor Microenvironment | 1 | 2021 | 566 | 0.030 |
Why?
|
Insulin | 1 | 2022 | 1203 | 0.030 |
Why?
|
Ubiquitin Thiolesterase | 1 | 2017 | 62 | 0.030 |
Why?
|
Risk Factors | 1 | 2011 | 10278 | 0.030 |
Why?
|
Protein Binding | 1 | 2001 | 1747 | 0.030 |
Why?
|
Phagocytosis | 1 | 2017 | 170 | 0.030 |
Why?
|
Iron | 1 | 1999 | 276 | 0.030 |
Why?
|
Pyridoxaminephosphate Oxidase | 1 | 1996 | 1 | 0.030 |
Why?
|
DEAD-box RNA Helicases | 1 | 2017 | 131 | 0.030 |
Why?
|
Caspase 2 | 1 | 2015 | 28 | 0.030 |
Why?
|
Syk Kinase | 1 | 2015 | 16 | 0.030 |
Why?
|
Primary Cell Culture | 1 | 2015 | 103 | 0.030 |
Why?
|
Gene Expression Regulation, Leukemic | 1 | 2015 | 63 | 0.030 |
Why?
|
Treatment Outcome | 1 | 2010 | 12269 | 0.030 |
Why?
|
AC133 Antigen | 1 | 2014 | 36 | 0.030 |
Why?
|
Eukaryotic Initiation Factor-4G | 1 | 2014 | 41 | 0.030 |
Why?
|
Poly(A)-Binding Proteins | 1 | 2014 | 22 | 0.030 |
Why?
|
Ribosomal Protein S6 Kinases, 90-kDa | 1 | 2014 | 38 | 0.030 |
Why?
|
Osteoblasts | 1 | 2015 | 150 | 0.030 |
Why?
|
Brain | 2 | 2018 | 3012 | 0.030 |
Why?
|
HCT116 Cells | 1 | 2013 | 55 | 0.030 |
Why?
|
Sequence Deletion | 1 | 1996 | 528 | 0.030 |
Why?
|
Genetic Loci | 1 | 2015 | 342 | 0.030 |
Why?
|
RNA | 1 | 2017 | 573 | 0.030 |
Why?
|
Hematopoietic Stem Cells | 1 | 2018 | 538 | 0.030 |
Why?
|
Mitochondria | 1 | 2018 | 677 | 0.030 |
Why?
|
Stromal Cells | 1 | 2015 | 302 | 0.030 |
Why?
|
Homozygote | 1 | 2015 | 547 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2013 | 80 | 0.030 |
Why?
|
Calcium-Binding Proteins | 1 | 2015 | 324 | 0.030 |
Why?
|
Receptor, Macrophage Colony-Stimulating Factor | 1 | 1993 | 4 | 0.030 |
Why?
|
Genes, p53 | 1 | 1994 | 216 | 0.030 |
Why?
|
Mice, Nude | 1 | 2014 | 725 | 0.030 |
Why?
|
DNA, Neoplasm | 1 | 1994 | 306 | 0.030 |
Why?
|
Infant, Newborn | 2 | 2018 | 8272 | 0.030 |
Why?
|
Neoplasm Invasiveness | 1 | 2015 | 625 | 0.030 |
Why?
|
Cluster Analysis | 1 | 2013 | 402 | 0.020 |
Why?
|
Imidazoles | 1 | 2013 | 206 | 0.020 |
Why?
|
Real-Time Polymerase Chain Reaction | 1 | 2014 | 508 | 0.020 |
Why?
|
Trophoblasts | 1 | 1993 | 113 | 0.020 |
Why?
|
Piperazines | 1 | 2013 | 241 | 0.020 |
Why?
|
Organic Chemicals | 1 | 2011 | 58 | 0.020 |
Why?
|
Luminescent Measurements | 1 | 2011 | 56 | 0.020 |
Why?
|
Spheroids, Cellular | 1 | 2011 | 60 | 0.020 |
Why?
|
Mutation, Missense | 1 | 2015 | 879 | 0.020 |
Why?
|
Radiography | 1 | 2013 | 802 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2015 | 2413 | 0.020 |
Why?
|
CD3 Complex | 1 | 2010 | 91 | 0.020 |
Why?
|
Baculoviral IAP Repeat-Containing 3 Protein | 1 | 2009 | 5 | 0.020 |
Why?
|
Polymerase Chain Reaction | 2 | 2008 | 1591 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2011 | 737 | 0.020 |
Why?
|
Diploidy | 1 | 2008 | 36 | 0.020 |
Why?
|
Immunohistochemistry | 2 | 2007 | 1701 | 0.020 |
Why?
|
Retrospective Studies | 2 | 2018 | 16334 | 0.020 |
Why?
|
Transcription Factors | 1 | 1997 | 2603 | 0.020 |
Why?
|
Phosphoproteins | 1 | 2009 | 419 | 0.020 |
Why?
|
Aged | 1 | 2004 | 19653 | 0.020 |
Why?
|
Genes, myc | 1 | 2006 | 105 | 0.020 |
Why?
|
DNA, Complementary | 1 | 2007 | 463 | 0.020 |
Why?
|
Chromosomes, Human, Pair 2 | 1 | 2006 | 119 | 0.020 |
Why?
|
Genes, Neoplasm | 1 | 2006 | 83 | 0.020 |
Why?
|
Genetic Markers | 1 | 2008 | 605 | 0.020 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2009 | 623 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2007 | 825 | 0.010 |
Why?
|
Heterozygote | 1 | 2007 | 672 | 0.010 |
Why?
|
Cell Cycle Proteins | 1 | 2009 | 651 | 0.010 |
Why?
|
Blotting, Western | 1 | 2007 | 1109 | 0.010 |
Why?
|
False Positive Reactions | 1 | 2004 | 144 | 0.010 |
Why?
|
Prospective Studies | 1 | 2014 | 6122 | 0.010 |
Why?
|
Microsatellite Repeats | 1 | 2004 | 222 | 0.010 |
Why?
|
Blotting, Northern | 2 | 1994 | 263 | 0.010 |
Why?
|
Gene Expression | 1 | 2007 | 1550 | 0.010 |
Why?
|
Molecular Sequence Data | 2 | 1998 | 3889 | 0.010 |
Why?
|
Apoproteins | 1 | 1999 | 18 | 0.010 |
Why?
|
Metal Metabolism, Inborn Errors | 1 | 1999 | 7 | 0.010 |
Why?
|
Gestational Age | 2 | 1994 | 1169 | 0.010 |
Why?
|
Spleen | 1 | 1999 | 281 | 0.010 |
Why?
|
Amino Acyl-tRNA Synthetases | 1 | 1998 | 26 | 0.010 |
Why?
|
Genomics | 1 | 2004 | 1520 | 0.010 |
Why?
|
Homeostasis | 1 | 1999 | 704 | 0.010 |
Why?
|
Evaluation Studies as Topic | 1 | 1994 | 257 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 1998 | 2709 | 0.010 |
Why?
|
Liver | 1 | 1999 | 1747 | 0.010 |
Why?
|
In Situ Hybridization | 1 | 1993 | 472 | 0.010 |
Why?
|
Pregnancy | 2 | 1994 | 7215 | 0.010 |
Why?
|
Phenotype | 1 | 1999 | 4266 | 0.010 |
Why?
|
Time Factors | 1 | 1999 | 6296 | 0.000 |
Why?
|
Antibodies, Monoclonal | 1 | 1993 | 1021 | 0.000 |
Why?
|